相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apigenin: A dietary flavonoid with diverse anticancer properties
Josip Madunic et al.
CANCER LETTERS (2018)
Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
Feifei Teng et al.
CANCER LETTERS (2018)
The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms
Taishu Wang et al.
CELL COMMUNICATION AND SIGNALING (2018)
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
Haidong Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
Matthew Dankner et al.
ONCOGENE (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
Anchalee Rawangkan et al.
MOLECULES (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity
Zsofia Edit Papay et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2017)
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
Marisa Granato et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra et al.
NATURE (2017)
Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
Guangming Zhao et al.
ONCOLOGY REPORTS (2017)
Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
Xiaohui Yan et al.
CELL AND BIOSCIENCE (2017)
The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status
Mengying Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Mechanisms and Strategies to Overcome Resistance to Molecularly Targeted Therapy for Melanoma
Su Yin Lim et al.
CANCER (2017)
Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation
Richard Greil et al.
CELL COMMUNICATION AND SIGNALING (2017)
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
Kemal Catakovic et al.
CELL COMMUNICATION AND SIGNALING (2017)
Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions
Rashida Ginwala et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
Melanie R. Power Coombs et al.
CANCER LETTERS (2016)
Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells
Yingqiu Zhang et al.
CANCER LETTERS (2016)
Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
Masaki Mandai et al.
CLINICAL CANCER RESEARCH (2016)
Curcumin: A new candidate for melanoma therapy?
Hamed Mirzaei et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Natural Polyphenols for Prevention and Treatment of Cancer
Yue Zhou et al.
NUTRIENTS (2016)
Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells
Hye-Sook Seo et al.
BIOSCIENCE REPORTS (2015)
STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer
Budiman Kharma et al.
CANCER RESEARCH (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
In vitro anti-inflammatory effect of apigenin in the Helicobacter pylori-infected gastric adenocarcinoma cells
Yuan-Chuen Wang et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets
Daniel Arango et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
Martina J. Schmitt et al.
CELL COMMUNICATION AND SIGNALING (2012)
Melanoma: New Insights and New Therapies
Vasiliki A. Nikolaou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Apigenin: A Promising Molecule for Cancer Prevention
Sanjeev Shukla et al.
PHARMACEUTICAL RESEARCH (2010)
Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy
R. R. Ruela-de-Sousa et al.
CELL DEATH & DISEASE (2010)
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
Kavon Rezai-Zadeh et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
KA Sheppard et al.
FEBS LETTERS (2004)
Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells
S Gupta et al.
ONCOGENE (2002)
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
CV Ramana et al.
TRENDS IN IMMUNOLOGY (2002)
分享论文
